Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Supporting trend data: Nationwide GLP-1 access research published by Honest Care shows that over 50% of patients seeking GLP-1 coverage now face full formulary exclusions as insurers tighten policies heading into 2026, aligning with the latest BCBS reductions across multiple states
6 In another study of people without diabetes, Saxenda was more effective for weight loss than lifestyle interventions alone, and weight loss was sustained for more than two years
Key trial results 32% of people on Mounjaro lost at least 25% of their body weight, compared to 16% on Wegovy
[3] [4] Semaglutide carries a warning about diabetic retinopathy complications, and all agents can cause hypoglycemia when used with insulin or sulfonylureas
Association between use of liraglutide and liver fibrosis in patients with type 2 diabetes
-1775582746855.png&w=3840&q=75)
